GHO Capital Partners Mergers and Acquisitions Summary

Private Equity Firm Profile

In the last 3 years, GHO Capital Partners has acquired 4 companies. It has also invested in 1 other.

GHO Capital Partners’ most common sectors for investment arelife science (67%) and business services (12%) . The Firm’s most common investment types include secondary buyout (56%) and buyout (lbo, mbo, mbi) (28%). In total, GHO Capital Partners has invested in 5 US states and 8 different countries. Its largest (disclosed) acquisition occurred in 2015 when it acquired DNA Diagnostics Center for $110M.

In the last 3 years, GHO Capital Partners has exited 1 company. The Firm’s most common exit type is trade sale (34%).

Join Mergr to view GHO Capital Partners’ full profile and discover more large private equity firm investors just like it.

M&A Summary

  • M&A Total Activity21
    • M&A Buy Activity18
    • M&A Sell Activity3
  • Total Sectors Invested 6
  • Total Countries Invested 8
  • M&A Buy/Sell Connections 2
  • M&A Advisors 12

GHO Capital Partners LLP

21 St James’s Square,
London, SW1Y 4JZ
United Kingdom
+44 20 3700 7440
www.ghocapital.com
enquiries@ghocapital.com

GHO Capital Partners is a private investment firm focused on the healthcare sector. The Firm will consider opportunities throughout Europe and seeks well-established, profitable businesses that have the potential to deliver a combination of double-digit top line growth, significant efficiency gains and international expansion. GHO Capital Partners was established in 2014 and is based in London.


Investment Criteria

Sectors of Interest: Healthcare Services, Life Science, Medical Products

Target Transaction Types: Buyout (LBO, MBO, MBI), Divestiture, Secondary Buyout

Geographic Preferences: United Kingdom, Western Europe, Eastern Europe, Nordic

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA - -
Investment Size - -
Enterprise Value - -

M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (1.6/yr) # 10 3 4 1 - - 18
vol $110M $110M
Sell (0.2/yr) # 2 - 1 - - - 3
  21

Most Recent M&A

Company Date Value Type
Alcami Corp., Inc. 2022-11-08 - Secondary Buyout
Wilmington, North Carolina · www.alcaminow.com
Biocare Medical LLC 2021-12-09 - Secondary Buyout
Pacheco, California · www.biocare.net
Genesis Research LLC 2021-11-16 - Secondary Buyout
Hoboken, New Jersey · www.genesisrg.com
Sanner GmbH 2021-10-26 - Growth Capital
Bensheim, Germany · www.sanner-group.com
DNA Diagnostics Center, Inc. 2021-06-28 - Trade Sale
Fairfield, Ohio · www.dnacenter.com
Velocity Clinical Research, Inc. 2021-04-08 - Secondary Buyout
Durham, North Carolina · www.velocityclinical.com
X-Chem, Inc. 2020-06-03 - Divestiture
Waltham, Massachusetts · www.x-chemrx.com
FairJourney Biologics SA 2020-01-30 - Growth Capital
Porto, Portugal · www.fjb.pt
Ardena Holding NV 2020-01-09 - Secondary Buyout
Mariakerke, Belgium · www.ardena.com
CellCarta 2019-07-31 - Secondary Sale
Montreal, Quebec · www.cellcarta.com
View All >>

Portfolio M&A

Company Acquired Add-On/Sale Date #
Velocity Clinical Research, Inc. 2021-04-08 VitaLink Research 2021-09-22 3
Durham, North Carolina · www.velocityclinical.com Greenville, South Carolina · www.vitalinkresearch.com
Velocity Clinical Research, Inc. 2021-04-08 National Research Institute 2021-09-22 2
Durham, North Carolina · www.velocityclinical.com Los Angeles, California · www.nritrials.com
Sterling Pharma Solutions 2019-02-12 ADC Biotechnology Ltd. 2021-04-07 3
Northumberland, United Kingdom · www.sterlingpharmasolutions.com Deeside, United Kingdom · www.adcbio.com
Envision Pharma, Inc. 2016-07-06 Two Labs LLC 2020-11-12 3
Horsham, United Kingdom · www.envisionpharmagroup.com Powell, Ohio · www.twolabs.com
Sterling Pharma Solutions 2019-02-12 Alcami Corp. - API Facility 2020-10-01 2
Northumberland, United Kingdom · www.sterlingpharmasolutions.com Germantown, Wisconsin

M&A by Sector

Sector Current # Value All-time # Value
Life Science 9 (60%) - 12 (67%) 110M (100%)
Business Services 2 (13%) - 2 (11%) -
Healthcare Services 1 (7%) - 1 (6%) -
Information Technology 1 (7%) - 1 (6%) -
Packaging 1 (7%) - 1 (6%) -
Test/Measurement Equipment 1 (7%) - 1 (6%) -
Total 15 - 18 $110M

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 7 (47%) - 8 (44%) 110M (100%)
  North Carolina 3 (20%) - 3 (17%) -
  California 2 (13%) - 2 (11%) -
  New Jersey 1 (7%) - 1 (6%) -
  Massachusetts 1 (7%) - 1 (6%) -
  Ohio - - 1 (6%) 110M (100%)
United Kingdom 2 (13%) - 3 (17%) -
Germany 2 (13%) - 2 (11%) -
Spain 1 (7%) - 1 (6%) -
Belgium 1 (7%) - 1 (6%) -
Netherlands 1 (7%) - 1 (6%) -
Portugal 1 (7%) - 1 (6%) -
Canada - - 1 (6%) -
  Quebec - - 1 (6%) -
Total 15 - 18 $110M

Acquisitions by Deal Type

Type Current # Value All-time # Value
Secondary Buyout 7 (47%) - 10 (56%) 110M (100%)
Buyout (LBO, MBO, MBI) 5 (33%) - 5 (28%) -
Growth Capital 2 (13%) - 2 (11%) -
Divestiture 1 (7%) - 1 (6%) -
Total 15 - 18 $110M

Exits by Deal Type

Type Total # Value
Recapitalization 1 (33%) -
Secondary Sale 1 (33%) -
Trade Sale - Public Company 1 (33%) -
Total 3 -

Top M&A Advisors

Financial Deals
Deloitte
4
Alvarez & Marsal
3
DNA Capital
1
Legal Deals
Ropes & Gray
8
Macfarlanes
1
Blake, Cassels & Graydon LLP
1

Deal Values

buy # Total
$100M to $1B 1 $110M
TOTAL $110M
Largest DNA Diagnostics Center, Inc.
$110M (2015-10-13)

M&A Connections

Deals
Acquired from
Investor(s)
56%
10 (56%)
Strategic(s)
6%
1 (6%)
Exited to
Investor(s)
67%
2 (67%)
Strategic(s)
33%
1 (33%)

FAQ

When was GHO Capital Partners LLP founded?

GHO Capital Partners LLP was founded in 2014.

What type of investor is GHO Capital Partners LLP?

GHO Capital Partners LLP is a private equity firm.

Where is GHO Capital Partners LLP headquartered?

GHO Capital Partners LLP is headquartered in London, United Kingdom.

How much capital does GHO Capital Partners LLP have under management?

GHO Capital Partners LLP has 5.0B EUR under management.

 Subscribe to unlock this and 202,656
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.